Huda Y Zoghbi sold $1.1M of Regeneron Pharmaceuticals (REGN)

Executed Feb 19, disclosed Feb 23, 4 days later.

Value, as filed

$1.1M

1,426 sh across 6 lots

Executed

Feb 19

the trade date, as filed

Disclosed

Feb 23

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Huda Y Zoghbi Director profile →

Huda Y Zoghbi (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $1.1M of REGN (1,426 sh across 6 lots, as filed), executed Feb 19.

The name

REGN

Regeneron Pharmaceuticals, Inc. REGN · Healthcare · 29 filings in 24 months ticker →

Healthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Huda Y Zoghbi in REGN

REGNSALE Regeneron Pharmaceuticals, Inc. $640K
800 sh × $800.00
Exec Aug 10
Filed Aug 12 · 4:14 PM ET